Document Type : Original Article
Authors
1 1 Department of Health Education and Promotion, School of Public Health, Tehran University of Medical Sciences
2 Department of Health Education and Promotion, School of Public Health, Shahid Beheshti University of Medical Sciences
3 Department of Nutrition, School of Nutrition, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Considering the effect of socio-economic factors on the emergence of chronic
diseases and the importance of this aspect of diseases for policy makers and authorities of
health care organizations, this study tried to investigate the role of these factors in type 2
diabetes and its consequences, which can be used in health policy making for preventing
from this disease. Materials and Methods: This descriptive-analytical study was conducted
on 384 diabetic patients who were admitted to a diabetes center in the city of Isfahan. The
participants were selected using simple random sampling. A questionnaire with 42 questions
was used for gathering the data which were analyzed using chi-square and Fisher’s statistical
tests. Results: The studied population consisted of 52.1% male and 47.9% female participants.
There was a statistically significant relationship between diabetes complications, age group,
educational level, job status, relationship with family members, number of family visits and
the reassurance provided by the family, type of leisure time activities, health status, years with
diabetes, smoking, type of treatment, fried food consumption and income (P < 0.001), sense
of security and communication in living environment (P < 0.002) and daily intake of vegetables
(P < 0.02). Conclusion: It seems that the application of supportive resources and secondary
strategies is an essential issue in the patients with chronic diseases, particularly diabetes.
Empowering strategies can induce basic changes in order to increase positive expectations,
hope, self-esteem and self- confidence in patients; this is the exact strategy which must be
used to efficiently control diabetes and its different types of complications among patients.
Keywords
prevalent disease in Iran. 1st ed. Tehran: Eshtiagh Publication:
2000; 32.P.35-39 [Persian].
2. Spinaci S, Currat L, Shetty P, Crowell V, Kehler J. Tough Choices:
Investing in health for development: Experiences from national
follow-up to commission on macroeconomics and health. WHO
Report 2006.
3. International Diabetes Federation. Diabetes Atlas. 3rd ed. Brussels,
Belgium: International Diabetes Federation; 2006.P.50-78
4. Deputy of Health, Deputy for research and technology. National
health situation states. Tehran: Tabalwor Publishing Group; 2003.
p. 59.
5. Hazavehei SM, Sharifirad G, Mohabi S. The effect of Educational
program based on Health Belief Model on diabetic foot care. Int J
Diabetes Dev Ctries 2007;27:18-23.
6. Ashidi M. Annual Diabetic Research Center Report in Shiraz 2008:36.
7. Amini M, Khadivi R. Direct medical costs of nephropathy resulting
from type II diabetes in Isfahan. Iranian Journal of Endocrinology
& Metabolism 1999;1:223-15.
8. Azizi F, Hatami H, Janghorbani M. Epidemiology and controlling
prevalent disease in Iran. 1st ed. Tehran: Eshtiagh Publication:
2000; 32.P.35-39 [Persian]
9. Falahati M. Survey of practice in diabetic control, diabetic patient’s
type 2, referee to diabetic research centre of Yazd. Ms Thesis, Yazd
University of medical sciences 2000. p. 34-45.
10. Ghanadi Fazlolah in translate diabetes (patient’s education). Rabert
M, Jams B. Printing 1, Isfahan: Kankash publication; 1998. p. 9.
11. Shahshahan T, Karimi J. Prevention principles of 2 diabetes, printing
1, Isfahan: Charbagh publication; 2002. p. 13-31.
12. Connolly VM, Roper NA, Unwin NC, Jones SC, Bilous RW, Kelly WF.
Quality of diabetes care, material deprivation and mortality. Diabet
Med 2002;19(Supplement 2):47.
13. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R.
Monitoring Blood glucose control in diabetes mellitus: A systematic
review HTA 2002; 4(12):1-5.
14. Mahdavi Hazaveh A, Delaveri A. Prevention and controlling program
of diabetes. Health Counselor of Disease Management Center, 2004;
53 [Persian].
15. Ortegon MM, Redekop WK, Niessen LW. Cost-effectiveness of
prevention and treatment of diabetic foot: A Markov analysis.
Diabetes Care 2004;27(4):901-7.
16. Amini M, Khadivi R, Haghighi S. Costs of type 2 diabetes in Isfahan,
Iran. Iranian Journal of Endocrinology & Metabolism 2002;4:104-97.
17. Krishnan S, Cozier Y, Rosenberg L, Palmer JR. Socioeconomic status
and incidence of type 2 diabetes: Results from the Black Women’s
Health Study. Am J Epidemiol 2010;171:546-70.
18. Everson SA, Maty SC, Lynch JW, Kaplan GA. Epidemiologic
evidence for the relation between socioeconomic status and
depression, obesity, and diabetes. J Psychosom Res 2002;
53(4):891-5.
19. Schootman M, Andresen EM, Wolinsky FD, Malmstrom TK, Miller JP,
Yan Y, et al. The effect of adverse housing and neighborhood
conditions on the development of diabetes mellitus among middleaged African Americans. Am J Epidemiol 2007;166:379-87.
20. Robinson N, Lloyd CE, Stevens LK. Social deprivation and mortality
in adults with diabetes mellitus. Diabet Med 1998;15:205-12.
21. UK prospective Diabetes Study Group. Intensive blood-glucose
control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). Lancet 1998;352:837-53.
22. Larrañaga I, Arteagoitia JM, Rodriguez JL, Gonzalez F, Esnaola S,
Piniés JA, et al. Socio economic inequalities in the prevalence
of Type 2 diabetes, cardiovascular risk factors and chronic
diabetic complications in the Basque Country, Spain. Diabet Med
2005;22:1047-53.
23. Antonovsky A. Social class, life expectancy and overall mortality.
Milbank Mem Fund Q 1967;45:37-73.
24. Rappaport J. Terms of empowerment/exemplars of prevention:
Toward a theory for community psychology. Am J Community
Psychol 1987;15:121-48
)